Johnson and Johnson stock, live, through the tokenised share

Signals, right now

The consumer brands people associate with the name were spun out

Plasters, baby shampoo and the other household products now sit in a separately listed company. What remains is pharmaceuticals and medical devices. Anyone forming a view from the brand they grew up with is valuing a business that no longer belongs to this share, and it is the most common error made about this ticker.

Litigation is a standing item here in a way it is not for most companies

Long-running claims over a discontinued consumer product have been through several attempted settlements and restructurings, and the eventual cost is genuinely unknown rather than merely uncertain. That is why this share can move sharply on a court docket entry with no change in any product or any sale. When the chart above steps with no results and no trial data, a ruling is the first thing to look for.

Two businesses with different clocks sit inside one price

Devices sell on hospital capital budgets and move slowly; pharmaceuticals move on trial readouts and patent dates, which arrive on specific days. The realised volatility below is an average across both, so it understates how violent the pharmaceutical half can be and overstates the device half. Reading them apart needs the segment disclosure, not a chart.

The token, the float, and what we checked

A custodian holds the share and a token is issued against it that quotes continuously on Solana. This is one of the thinner tokenised shares: the value in issue is small and days pass with very little trading, so the price can sit unchanged while the real share moves. When this page was built the two agreed to within a quarter of one percent. For the official price, use the NYSE or a broker.